Lasa Supergenerics Appoints Mrs. Mitti Jain as Company Secretary & Compliance Officer
Lasa Supergenerics Limited appoints Mrs. Mitti Jain as Company Secretary and Compliance Officer, effective December 16, 2025. Mrs. Jain, an Associate Member of ICSI with 10 years of experience, will also be a Key Managerial Personnel.
The change in Company Secretary is a standard regulatory requirement and typically has a low direct impact on the company's operations or financial performance.
The appointment of a new Company Secretary and Compliance Officer is a routine corporate governance event and does not inherently carry a positive or negative financial implication for the company.
Lasa Supergenerics Limited has announced the appointment of Mrs. Mitti Jain as the new Company Secretary and Compliance Officer, who will also serve as a Key Managerial Personnel. This appointment is effective from December 16, 2025, in accordance with the provisions of the Companies Act, 2013, and SEBI regulations.
Mrs. Mitti Jain is an Associate Member of the Institute of Company Secretaries of India and holds degrees in B.com and M.com. She brings approximately 10 years of extensive experience in corporate laws and related matters to the company. The terms of her appointment will be governed by the appointment letter issued by the company.
This change is in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed BSE Limited and the National Stock Exchange of India Limited about this development. Further details can be found on the company's website and the stock exchanges' websites.
What to do with a filing like this
Lasa Supergenerics Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lasa Supergenerics Limited. Read the original for the full detail.